tiprankstipranks
Cybeats Technologies Corp. (TSE:CYBT)
:CYBT
Canadian Market

Cybeats Technologies Corp. (CYBT) AI Stock Analysis

Compare
16 Followers

Top Page

TS

Cybeats Technologies Corp.

(CYBT)

42Neutral
Cybeats Technologies Corp. faces significant financial challenges with persistent losses and a weak balance sheet, reflected in the low financial performance score. However, recent strategic contracts in healthcare and industrial control systems sectors provide positive market expansion signals, slightly improving the overall outlook. Technical indicators show bearish trends, and valuation metrics remain unfavorable due to continued losses.

Cybeats Technologies Corp. (CYBT) vs. S&P 500 (SPY)

Cybeats Technologies Corp. Business Overview & Revenue Model

Company DescriptionCybeats Technologies Corp. (CYBT) is a cybersecurity company specializing in the development of software solutions to enhance the security of Internet of Things (IoT) devices and infrastructure. The company provides tools that help manufacturers and enterprises manage and mitigate cybersecurity risks throughout the lifecycle of their IoT products. Cybeats' core products focus on Supply Chain Risk Management, including Software Bill of Materials (SBOM) management and continuous monitoring of device security.
How the Company Makes MoneyCybeats Technologies Corp. generates revenue primarily through the sale of its cybersecurity software solutions. The company's revenue model includes licensing fees for its software products and subscription-based services for continuous security monitoring and management. Key revenue streams include direct sales to IoT manufacturers, enterprises, and other organizations seeking to secure their IoT infrastructure. Additionally, Cybeats may engage in strategic partnerships with technology firms to expand its market reach and integrate its solutions into broader cybersecurity offerings, further contributing to its earnings.

Cybeats Technologies Corp. Financial Statement Overview

Summary
Cybeats Technologies Corp. shows strong revenue growth with a 61.5% increase, but consistently reports negative net income and EBIT, indicating persistent operational challenges. The balance sheet is weak with negative stockholders' equity, high leverage, and liabilities exceeding assets. Although there's an improvement in free cash flow, the company remains reliant on financing for operations.
Income Statement
45
Neutral
The company's TTM revenue increased by 61.5% compared to the previous year, indicating strong growth. However, it has consistently reported negative net income and EBIT, resulting in negative profit margins. The gross profit margin stands at a healthy 96.1%, but negative EBIT and EBITDA margins highlight ongoing operational challenges.
Balance Sheet
30
Negative
The company has a negative stockholders' equity, suggesting high leverage and potential financial instability. The debt-to-equity ratio cannot be calculated due to negative equity. Total liabilities significantly exceed total assets, indicating a precarious financial position.
Cash Flow
40
Negative
The operating cash flow is negative, but there is a notable improvement in free cash flow from the previous year. The free cash flow to net income ratio indicates better cash generation relative to losses. However, the company is still heavily reliant on financing activities to sustain operations.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
1.89M1.17M114.52K0.00371.08K0.00
Gross Profit
1.82M1.12M-107.70K0.0086.76K0.00
EBIT
-7.80M-10.17M-7.53M-146.31K
EBITDA
-9.16M-10.09M-19.97M-146.31K
Net Income Common Stockholders
-9.94M-10.34M-6.77M-146.31K
Balance SheetCash, Cash Equivalents and Short-Term Investments
14.05K35.70K379.35K13.44K14.26K35.09K
Total Assets
14.05K1.86M1.38M13.44K14.26K35.09K
Total Debt
0.001.46M750.63K0.0040.00K
Net Debt
-14.05K1.42M371.28K-13.44K25.74K
Total Liabilities
276.58K4.77M2.55M403.46K252.24K191.12K
Stockholders Equity
-2.90M-1.17M-390.03K
Cash FlowFree Cash Flow
-4.44M-9.24M-15.65M5.31K
Operating Cash Flow
-4.44M-9.24M-15.43M5.31K
Investing Cash Flow
-499.28K-145.29K-229.52K0.00-15.65K0.00
Financing Cash Flow
5.04M9.23M16.02M-6.11K699.36K0.00

Cybeats Technologies Corp. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.13
Price Trends
50DMA
0.12
Positive
100DMA
0.13
Negative
200DMA
0.15
Negative
Market Momentum
MACD
<0.01
Positive
RSI
55.11
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYBT, the sentiment is Negative. The current price of 0.13 is below the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.12, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 55.11 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CYBT.

Cybeats Technologies Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$1.42B16.7414.76%4.34%8.11%15.83%
69
Neutral
$9.58B10.7516.00%4.16%-3.59%432.46%
TSCLS
68
Neutral
C$11.28B19.4923.36%23.03%81.01%
TSKXS
68
Neutral
C$4.59B157.81-0.10%14.85%-105.25%
57
Neutral
$20.94B10.43-13.41%2.52%4.53%-23.34%
TSBB
50
Neutral
$2.64B-7.59%-26.72%77.64%
42
Neutral
162.73%130.24%8.72%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CYBT
Cybeats Technologies Corp.
0.13
-0.08
-38.10%
TSE:BB
BlackBerry
4.42
0.50
12.76%
TSE:ENGH
Enghouse Systems
24.66
-4.48
-15.38%
TSE:OTEX
Open Text
35.01
-13.97
-28.52%
TSE:CLS
Celestica
97.27
32.14
49.35%
TSE:KXS
Kinaxis Inc
163.21
16.30
11.10%

Cybeats Technologies Corp. Corporate Events

Business Operations and StrategyFinancial Disclosures
Cybeats Expands in Healthcare Sector with Strategic Contracts and Strong Revenue Growth
Positive
Jan 30, 2025

Cybeats Technologies Corp. has announced two new strategic contracts with healthcare organizations, strengthening its position in the SBOM management market, particularly in the medical device manufacturing sector. The company reported a 148% net revenue retention rate for 2024 and over $7 million in total contract commitments, showcasing strong financial performance and market growth. Cybeats is also enhancing its product offerings and brand presence, and will participate in the S4x25 cybersecurity conference to further expand its pipeline and industry influence.

Product-Related AnnouncementsBusiness Operations and Strategy
Cybeats Secures Major Contract with Rockwell Automation for Software Supply Chain Security
Positive
Jan 28, 2025

Cybeats Technologies Corp. has signed a significant three-year contract with Rockwell Automation to provide their SBOM Studio for software supply chain management. This agreement highlights Cybeats’ expanding influence in the industrial control systems sector, emphasizing the growing demand for robust software supply chain solutions across critical industries. The contract with Rockwell Automation reinforces Cybeats’ position as a trusted provider of complex product security solutions and supports organizations in streamlining software vulnerability management and regulatory compliance.

Cybeats Technologies Grows Amid Rising SBOM Demand
Dec 18, 2024

Cybeats Technologies Corp. is experiencing strong commercial growth with over $7 million in contract commitments and a 72% increase in customer spending in 2024, highlighting its leadership in the SBOM management market. The company raised $1.65 million to enhance its sales and marketing infrastructure, positioning it well to capitalize on the increasing demand for SBOM solutions as organizations prioritize software supply chain security. With a focus on healthcare and manufacturing sectors, Cybeats aims to deliver long-term value to its clients and investors.

Cybeats Technologies Secures Major Medical Tech Contract
Dec 9, 2024

Cybeats Technologies Corp. has secured a significant contract with a top global medical device manufacturer, marking its fourth such client in the sector. This partnership highlights the growing demand for Cybeats’ SBOM Studio, driven by regulatory pressures and the need for enhanced cybersecurity in the medical field.

Cybeats Strengthens Advisory Board with Key Appointments
Dec 4, 2024

Cybeats Technologies Corp. has bolstered its advisory board with the addition of cybersecurity experts Kurt Callewaert and Bob Haack. Their extensive experience will help Cybeats enhance its software supply chain security and navigate complex regulatory landscapes. These appointments underscore Cybeats’ commitment to innovation and leadership in the cybersecurity sector.

Cybeats Teams Up with Sophic Capital for Growth
Dec 2, 2024

Cybeats Technologies Corp. has appointed Sophic Capital as its investor relations partner to enhance investor awareness and communicate its growth strategy effectively. This collaboration aims to leverage Sophic’s capital markets expertise to introduce Cybeats to a broader investment community as the company addresses global cybersecurity challenges. The partnership includes a financial agreement involving a monthly fee and stock options.

Cybeats Unveils $5M Private Placement Offering
Nov 17, 2024

Cybeats Technologies Corp. has announced a non-brokered private placement offering to raise up to $5 million by selling 31.25 million units of the company. Each unit includes a common share and a warrant, with the funds aimed at bolstering sales, marketing, and working capital. This move replaces a previous financing plan to enhance flexibility and align with long-term goals.

Cybeats Leverages U.S. Army’s SBOM Mandate
Nov 12, 2024

Cybeats Technologies Corp. is poised to capitalize on the U.S. Army’s new mandate for Software Bills of Materials (SBOMs), enhancing software security and transparency. Their SBOM Consumer product is designed to help organizations like the Army manage and validate SBOMs, ensuring compliance and improving security measures. With this development, Cybeats positions itself as a strategic partner in strengthening the U.S. military’s software supply chain security.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.